What are the next steps in evaluating and managing an 18‑year‑old female with a one‑week history of sudden diffuse hair shedding (clumps on pillow/comb), recent shampoo change, hair washed every other day, taking a multivitamin (Enervon), family history of alopecia, high stress weekends, normal vital signs and Ludwig grade 1 scalp thinning without inflammation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acute Telogen Effluvium: Next Steps in Evaluation and Management

This 18-year-old female most likely has acute telogen effluvium triggered by stress, and the appropriate next steps are targeted laboratory testing (serum ferritin, TSH/free T4, vitamin D, zinc), dermoscopy to confirm the diagnosis and exclude alopecia areata, and reassurance that spontaneous resolution occurs in 80% of cases within 3–6 months once the trigger is addressed. 1, 2

Clinical Pattern Recognition

The presentation strongly suggests telogen effluvium rather than alopecia areata based on several key features:

  • Sudden onset of diffuse shedding (clumps on pillow, hair loss while combing) over one week is the hallmark of telogen effluvium, whereas alopecia areata typically presents with discrete patches 2, 3
  • Ludwig grade 1 diffuse thinning without inflammation points away from alopecia areata, which would show patchy loss with exclamation-mark hairs 1, 4
  • High stress from hectic weekends and schoolwork is a classic precipitant for telogen effluvium, which occurs 2–3 months after a physiologic or emotional stressor 2, 3
  • Poor nutrition (microwaved meals) raises concern for nutritional deficiencies that commonly trigger telogen effluvium 1, 2

Essential Diagnostic Steps

1. Dermoscopy (First-Line Diagnostic Tool)

Perform dermoscopy immediately to differentiate telogen effluvium from diffuse alopecia areata: 1, 4

  • Telogen effluvium shows: normal follicular openings, no yellow dots, no exclamation-mark hairs 1
  • Alopecia areata shows: yellow dots, exclamation-mark hairs, cadaverized hairs, and black dots 1, 4
  • Dermoscopy is the single most useful non-invasive tool and can obviate the need for scalp biopsy in most cases 1, 4

2. Targeted Laboratory Testing

Order the following labs because nutritional deficiencies and thyroid disorders are the two most common treatable causes of diffuse hair loss, often without obvious clinical features: 1, 2

  • Serum ferritin: Iron deficiency is the most common nutritional deficiency worldwide and a frequent cause of chronic diffuse telogen hair loss; optimal ferritin ≥60 ng/mL is needed for hair growth 1, 4
  • TSH and free T4: Thyroid disease commonly causes hair loss and must be excluded 1, 4
  • Vitamin D level: 70% of alopecia areata patients have deficiency (<20 ng/mL), and vitamin D plays a critical role in hair follicle cycling 1, 4
  • Serum zinc: Zinc deficiency impairs hair follicle function and levels tend to be lower in patients with hair loss 1, 4

Do NOT order extensive autoimmune panels unless dermoscopy reveals findings consistent with alopecia areata, as routine screening is not justified by the modest increase in autoimmune disease prevalence 5, 1

3. Additional Testing Only If Indicated

  • Fungal culture: Only if scalp shows inflammation or scaling suggestive of tinea capitis 5, 1, 4
  • Scalp biopsy: Reserved for cases where diagnosis remains uncertain after clinical examination and dermoscopy 5, 1, 4
  • Lupus serology: Only if systemic features (joint pain, photosensitivity, facial rash) are present 5, 1

Management Algorithm

Immediate Management (Week 1)

Provide strong reassurance that this represents excessive shedding rather than actual permanent hair loss and does not lead to baldness: 2, 6

  • Explain that telogen effluvium is self-limited and resolves in 3–6 months once the trigger is removed or treated 2, 3
  • Counsel that visible regrowth cannot be expected within the first 3 months 5, 4
  • Up to 80% of patients with limited-duration telogen effluvium experience spontaneous remission 1, 4

Address Modifiable Triggers

  • Stress management: The hectic schedule and schoolwork are likely precipitants; recommend stress-reduction strategies 2, 3
  • Nutritional optimization: Microwaved meals suggest poor nutrition; counsel on balanced diet rich in protein, iron, and vitamins 1, 2
  • Reassure about shampoo changes: Switching from Palmolive to Dove is unlikely to be causative or therapeutic; normal hair washing frequency (every other day) is appropriate 2

Treatment Based on Laboratory Results

If ferritin <60 ng/mL: Supplement iron to achieve optimal levels for hair growth 1, 4

If vitamin D <20 ng/mL: Supplement according to general international recommendations for adults 1, 4

If zinc deficiency confirmed: Zinc supplementation may contribute to hair health 1, 4

If TSH elevated with low free T4: Treat hypothyroidism appropriately 1, 4

Follow-Up Strategy

  • Recheck in 3 months to assess for spontaneous resolution 2, 3
  • If hair loss persists beyond 6 months or worsens, consider alternative diagnoses (chronic telogen effluvium, female pattern hair loss) and refer to dermatology 2, 6

Critical Differential Diagnosis Considerations

Alopecia Areata (Less Likely Here)

  • Would show discrete patches rather than diffuse thinning 1, 4
  • Exclamation-mark hairs on dermoscopy are pathognomonic 1, 4
  • Family history in brother increases suspicion, but clinical pattern does not fit 1, 7
  • If dermoscopy reveals yellow dots and exclamation-mark hairs, diagnosis shifts to alopecia areata and management changes to watchful waiting (34–50% spontaneous remission within one year) or intralesional corticosteroids for limited patches 5, 1, 4

Chronic Telogen Effluvium (If Persists >6 Months)

  • Excessive diffuse shedding from a normal-looking scalp without obvious cause 2, 6
  • May fluctuate for 3–10 years but is self-limiting in the long run 2, 6
  • Biopsy shows normal histology, distinguishing it from female pattern hair loss 2

Female Pattern Hair Loss (Less Likely at Age 18)

  • Gradual onset with central scalp thinning and widening of central part 2, 8
  • Would not present with sudden clumps of hair loss 2

Common Pitfalls to Avoid

  • Do not order extensive autoimmune panels for straightforward telogen effluvium; this adds no value and increases cost 5, 1, 4
  • Do not overlook the psychological impact: Hair loss can profoundly affect quality of life in young women; assess for anxiety or depression and provide mental health referral if needed 5, 1, 7
  • Do not confuse with trichotillomania: In trichotillomania, broken hairs remain firmly anchored in anagen phase, whereas telogen effluvium shows diffuse shedding of club hairs 5, 1, 4
  • Do not prescribe topical minoxidil for acute telogen effluvium; it is indicated for androgenetic alopecia, not stress-induced shedding 4, 2, 3
  • Do not biopsy routinely: Scalp biopsy is reserved for uncertain diagnoses after dermoscopy, not for classic telogen effluvium 5, 1, 4

References

Guideline

Hair Loss Causes and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Diffuse hair loss in an adult female: approach to diagnosis and management.

Indian journal of dermatology, venereology and leprology, 2009

Research

Hair Loss: Common Causes and Treatment.

American family physician, 2017

Guideline

Diagnosis and Management of Hair Loss

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Chronic telogen effluvium.

Dermatologic clinics, 1996

Guideline

Evaluating Patients with Alopecia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hair loss in women.

Seminars in cutaneous medicine and surgery, 2009

Related Questions

How should I evaluate and treat chronic telogen effluvium in a 30‑ to 50‑year‑old woman with diffuse, non‑scarring hair shedding lasting more than six months?
What are some treatment options for diffuse alopecia?
What is the diagnosis for a 27-year-old postpartum (postpartum period) woman presenting with telogen effluvium (hair thinning and falling out in clumps) eight weeks after a vaginal delivery, with normal vital signs and physical examination showing patches of hair loss with new hair growth?
What types of alopecia explain diffuse scalp thinning, shedding of long hair shafts with small roots, and an oily, itchy scalp with dandruff and inflamed follicles in a 33‑year‑old woman?
What is the best treatment approach for an adult or adolescent patient with diffuse hair loss and scalp symptoms?
What is the recommended antibiotic regimen for a patient with ventilator‑associated pneumonia caused by multidrug‑resistant Acinetobacter baumannii that is intermediate susceptible to colistin?
When is it appropriate to refer a patient for formal psychotherapy, specifically cognitive‑behavioral therapy, interpersonal therapy, or psychodynamic psychotherapy?
For a pregnant woman with ondansetron‑induced constipation, is lactulose (Nutalact) or sodium picosulfate (Picofit) the safer first‑line treatment?
In a patient with persistent abdominal pain who is taking chlordiazepoxide and the drug 'clinidium', are these appropriate first‑line therapies and how should they be managed?
How should I manage a 39-year-old woman with a 2-year history of chronic painless Raynaud phenomenon affecting both hands, mild sensory loss, no paresthesias, currently taking vitamin D and hydroxychloroquine 200 mg daily without improvement and a positive family history of autoimmune disease?
What is the appropriate management of confirmed varicella infection in a 1‑month‑old infant?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.